Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P8SU
|
|||
Former ID |
DNC008257
|
|||
Drug Name |
(R)-1-(4-nitrophenethyl)-2-methylpyrrolidine
|
|||
Synonyms |
CHEMBL440996; SCHEMBL1574678; PFZYNGPCNCRLFU-LLVKDONJSA-N; BDBM50372333; ZINC29131354
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H18N2O2
|
|||
Canonical SMILES |
CC1CCCN1CCC2=CC=C(C=C2)[N+](=O)[O-]
|
|||
InChI |
1S/C13H18N2O2/c1-11-3-2-9-14(11)10-8-12-4-6-13(7-5-12)15(16)17/h4-7,11H,2-3,8-10H2,1H3/t11-/m1/s1
|
|||
InChIKey |
PFZYNGPCNCRLFU-LLVKDONJSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series. Bioorg Med Chem Lett. 2008 Jan 1;18(1):355-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.